Farrokh Modabber

4.3k total citations
71 papers, 3.5k citations indexed

About

Farrokh Modabber is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Immunology. According to data from OpenAlex, Farrokh Modabber has authored 71 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Public Health, Environmental and Occupational Health, 26 papers in Epidemiology and 14 papers in Immunology. Recurrent topics in Farrokh Modabber's work include Research on Leishmaniasis Studies (46 papers), Trypanosoma species research and implications (20 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Farrokh Modabber is often cited by papers focused on Research on Leishmaniasis Studies (46 papers), Trypanosoma species research and implications (20 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Farrokh Modabber collaborates with scholars based in Switzerland, United States and Iran. Farrokh Modabber's co-authors include Ali Khamesipour, Yahya Dowlati, Iraj Sharifi, Sassan Noazin, Eltahir Awad Gasim Khalil, Peter G. Smith, Fábio Zicker, Piero Olliaro, Sima Rafati and R. Hashemi‐Fesharki and has published in prestigious journals such as Science, The Lancet and The Journal of Immunology.

In The Last Decade

Farrokh Modabber

68 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Farrokh Modabber Switzerland	35	3.0k	1.8k	722	537	337	71	3.5k
Eltahir Awad Gasim Khalil Sudan	34	3.1k 1.0×	2.1k 1.1×	362 0.5×	676 1.3×	350 1.0×	121	3.8k
Wilson Mayrink Brazil	38	3.7k 1.2×	2.2k 1.2×	687 1.0×	964 1.8×	273 0.8×	121	3.9k
Maria Norma Melo Brazil	42	3.5k 1.2×	2.2k 1.2×	494 0.7×	1.1k 2.1×	381 1.1×	117	4.1k
Amélia Ribeiro de Jesus Brazil	31	2.2k 0.7×	1.4k 0.8×	655 0.9×	1.1k 2.0×	412 1.2×	94	3.4k
Charles N. Oster United States	29	2.1k 0.7×	796 0.4×	342 0.5×	590 1.1×	584 1.7×	69	2.9k
D Pedral-Sampaio Brazil	22	1.9k 0.6×	1.5k 0.8×	367 0.5×	598 1.1×	516 1.5×	35	2.6k
Alexandre Barbosa Reis Brazil	39	3.9k 1.3×	2.5k 1.4×	827 1.1×	1.1k 2.1×	333 1.0×	154	4.5k
Carlos Henrique Nery Costa Brazil	34	2.9k 1.0×	1.6k 0.9×	411 0.6×	913 1.7×	273 0.8×	129	3.4k
Albert A. Gam United States	30	1.2k 0.4×	883 0.5×	594 0.8×	1.0k 1.9×	291 0.9×	48	2.6k
Manuel Soto Spain	40	3.3k 1.1×	2.5k 1.4×	998 1.4×	697 1.3×	219 0.6×	143	4.2k

Countries citing papers authored by Farrokh Modabber

Since Specialization

Citations

This map shows the geographic impact of Farrokh Modabber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farrokh Modabber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farrokh Modabber more than expected).

Fields of papers citing papers by Farrokh Modabber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farrokh Modabber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farrokh Modabber. The network helps show where Farrokh Modabber may publish in the future.

Co-authorship network of co-authors of Farrokh Modabber

This figure shows the co-authorship network connecting the top 25 collaborators of Farrokh Modabber. A scholar is included among the top collaborators of Farrokh Modabber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farrokh Modabber. Farrokh Modabber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thacker, Seth G., Béatrice Bonnet, Serge L. Beaucage, et al.. (2020). CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis. PLoS neglected tropical diseases. 14(2). e0008050–e0008050. 21 indexed citations

Modabber, Farrokh, et al.. (2015). A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis. PLoS neglected tropical diseases. 9(9). e0003889–e0003889. 78 indexed citations

Sundar, Shyam, Prabhat Kumar Sinha, Madhukar Rai, et al.. (2011). Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. The Lancet. 377(9764). 477–486. 239 indexed citations

Modabber, Farrokh. (2010). Leishmaniasis vaccines: past, present and future. International Journal of Antimicrobial Agents. 36. S58–S61. 66 indexed citations

Sharifi, Iraj, Alireza Fekri, Mohammad Reza Aflatoonian, et al.. (2010). Leishmaniasis recidivans among school children in Bam, South‐east Iran, 1994–2006. International Journal of Dermatology. 49(5). 557–561. 42 indexed citations

Musa, Ahmed, Sassan Noazin, Eltahir Awad Gasim Khalil, & Farrokh Modabber. (2009). Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration. Transactions of the Royal Society of Tropical Medicine and Hygiene. 104(1). 1–2. 33 indexed citations

Noazin, Sassan, Farrokh Modabber, Ali Khamesipour, et al.. (2008). First generation leishmaniasis vaccines: A review of field efficacy trials. Vaccine. 26(52). 6759–6767. 138 indexed citations

Vélez, Iván Darío, María Patricia Arbeláez, Carlos Rojas, et al.. (2005). Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 99(8). 593–598. 78 indexed citations

Khalil, Eltahir Awad Gasim, Ahmed Musa, Farrokh Modabber, et al.. (2003). Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers. Transactions of the Royal Society of Tropical Medicine and Hygiene. 97(3). 365–368. 48 indexed citations

10.

Khamesipour, Ali, Yahya Dowlati, Sima Rafati, et al.. (2003). Immune response measured in human volunteers vaccinated with autoclavedLeishmania majorvaccine mixed with low dose of BCG. Clinical & Experimental Immunology. 134(2). 303–308. 41 indexed citations

11.

Machado‐Pinto, Jackson, Jorge Pinto, Carlos Alberto da Costa, et al.. (2002). Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial. International Journal of Dermatology. 41(2). 73–78. 76 indexed citations

12.

Khalil, Eltahir Awad Gasim, et al.. (2000). Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. The Lancet. 356(9241). 1565–1569. 200 indexed citations

13.

Vélez, Iván Darío, María Patricia Arbeláez, Sara M. Robledo, et al.. (2000). Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial. Transactions of the Royal Society of Tropical Medicine and Hygiene. 94(6). 698–703. 41 indexed citations

14.

Momeni, Ali, Ali Khamesipour, Fábio Zicker, et al.. (1999). A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran. Vaccine. 17(5). 466–472. 131 indexed citations

15.

Neva, Franklin A., Carlos Ponce, Elisa Ponce, et al.. (1997). Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin. Transactions of the Royal Society of Tropical Medicine and Hygiene. 91(4). 473–475. 42 indexed citations

16.

Dowlati, Yahya, et al.. (1996). Comparative safety and immunogenicity trial of two killed Leishmania Major vaccines with or without BCG in human volunteers. Clinics in Dermatology. 14(5). 489–495. 49 indexed citations

17.

Modabber, Farrokh, Félix J. Tapia, G. Càceres‐Dittmar, & M. A. Sánchez. (1996). Vaccine: the only hope to control leishmaniasis.. 223–236. 4 indexed citations

18.

Modabber, Farrokh. (1989). Experiences with vaccines against cutaneous leishmaniasis: of men and mice. Parasitology. 98(S1). S49–S60. 78 indexed citations

19.

Modabber, Farrokh. (1987). A model for the mechanism of sensitivity of BALB/c mice to L. major and premunition in leishmaniases. Annales de l Institut Pasteur Immunologie. 138(5). 781–786. 9 indexed citations

20.

Swain, Susan L., Farrokh Modabber, & Albert H. Coons. (1976). Characterization of T and B antigen-binding cells for beta-galactosidase. I. beta-galactosidase-binding cells in the thymus and spleen of normal mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 116(4). 915–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact